The Lancet Respiratory Medicine in conversation with Podcast By The Lancet Group cover art

The Lancet Respiratory Medicine in conversation with

The Lancet Respiratory Medicine in conversation with

By: The Lancet Group
Listen for free

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COVID outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.© 2026 The Lancet Group Biological Sciences Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability

    Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability
    Mar 26 2026

    Anne-Marie Dingemans, Isabelle Opiz, and Corinne Faivre-Finn talk about their multidisciplinary efforts to develop a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability.

    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00051-2/fulltext

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
    Show more Show less
    28 mins
  • Anne Holland and Christine McDonald

    Anne Holland and Christine McDonald
    Mar 2 2026

    Anne Holland and Christine McDonald join Diana Stanley to discuss ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis.

    Click here to read the full article, Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a randomised sham-controlled trial

    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00005-6/fulltext

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
    Show more Show less
    12 mins
  • Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest

    Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest
    Dec 22 2025

    Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment.

    Click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00363-7/fulltext

    Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
    Show more Show less
    8 mins
No reviews yet